Current models suggest that ligand-binding heterogeneity in HER1 [human EGFR (epidermal growth factor receptor] arises from negative co-operativity in signalling HER1 dimers, for which the asymmetry of the extracellular region of the Drosophila EGFR has recently provided a structural basis. However, no asymmetry is apparent in the current crystal structure of the isolated extracellular region of HER1. This receptor also differs from the Drosophila EGFR in that negative co-operativity is found only in full-length receptors in cells. Structural insights into HER1 in epithelial cells, derived from FLIM (fluorescence lifetime imaging microscopy) and two-dimensional FRET (Förster resonance energy transfer) combined with Monte Carlo and molecular dynamics simulations, have demonstrated a high-affinity ligand-binding HER1 conformation consistent with the extracellular region aligned flat on the plasma membrane. This conformation shares key features with that of the Drosophila EGFR, suggesting that the structural basis for negative co-operativity is conserved from invertebrates to humans, but that, in HER1, the extracellular region asymmetry requires interactions with the plasma membrane.
Human epidermal growth factor receptor (HER1) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry HER1 is a prototypical receptor tyrosine kinase HER1 [human EGFR (epidermal growth factor receptor)] is a member of the growth factor RTK (receptor tyrosine kinase) superfamily. This family also comprises 18 subgroups of cell-surface receptors for many growth factors, cytokines and hormones [1] . The EGFR family has evolved from one receptor/one ligand in Caenorhabditis elegans, through one receptor/multiple ligands in Drosophila, to a family comprising four receptors and 13 extracellular ligands in mammals [2] .
The EGFR family are key regulators of cell-cell inductive processes and cell fate [3] . Their function is to transmit growth factor signals from the outside to the inside of the cell, where changes in gene expression allow the cell to respond to the new circumstances. Deregulated signalling by cell-surface HER1 (e.g. via activating mutations in the HER1 gene) is implicated in a substantial percentage of lung cancers [4] . As activation of these receptors has been shown to result in the growth and progression of the malignancy, there have been considerable research efforts directed towards the development of effective inhibitors of HER1. Several of these cancer drugs are in different stages of pre-clinical and clinical trials [5] .
Insights into signalling by HER1
The primary structure of HER1 is shared by all RTKs and consists of a single polypeptide chain (1186 amino acids) of 170 kDa, containing a heavily glycosylated 622-aminoacid N-terminal extracellular ligand-binding domain that is connected to the cytoplasmic domain by a single transmembrane helix of 23 residues. The 542-residue cytoplasmic domain contains a conserved 250-amino-acid tyrosine kinase core [6] . Ligand binding induces the dimerization of HER1 ectodomains. This leads to the formation of an asymmetric dimer by the two associated intracellular kinases [7] that is stabilized by the inner juxtamembrane region [8, 9] . In the ligand-mediated kinase dimer, kinase activation proceeds though an allosteric mechanism in which the C-lobe of one kinase 'pushes' the N-lobe of the other kinase towards the active site in an interaction that is highly reminiscent of the activation of CDK2 (cyclin-dependent kinase 2) by binding of cyclin A [10] (Figure 1 ). Active kinases then proceed to phosphorylate tyrosine residues in the 229-residue Cterminal tail of the receptor [7] , which, when phosphorylated, act as docking sites for a large repertoire of adapters and enzymes containing SH2 (Src homology 2) domains [11] . These include, for example, Grb2 (growth-factor-receptorbound protein 2), GAP (GTPase-activating protein), Shc, PLCγ (phospholipase Cγ ) and PI3K (phosphoinositide 3-kinase), which regulate Ras/Rho-like GTPases, Ca 2 + second messenger production and the Ras-activated MAPK (mitogen-activated protein kinase)/SAPK (stress-activated protein kinase) pathways [12] , leading to cell proliferation, changes in cell morphology, trafficking and the termination of signals via endocytosis of the receptor-ligand complexes [13] . [14, 15] and the cytoplasm where the two tyrosine kinase domains form an asymmetric dimer [7] . The relative disposition of the transmembrane domains and the C-terminal tails (depicted by the blue lines in which red spheres indicate autophosphorylation sites) is not known. Following recruitment of effectors such as Grb2, recruitment of Sos (Son-of-Sevenless) leads to the activation of Ras via exchange of GTP for GDP to activate the Ras-mediated signalling pathway, one of the pathways activated by HER1 dimerization and activation [11] .
The structure of the extracellular domain of HER1
Crystallographic studies of HER1 ectodomain fragments bound to two types of ligands, i.e. EGF (epidermal growth factor) and TGFα (transforming growth factor α), have shown quasi-asymmetric 2:2 ligand-receptor dimers [14, 15] . Unliganded HER1 monomers are held in a closed conformation by an intramolecular tether formed by loops in subdomains II and IV [16] [17] [18] . Results suggest that ligand binding and dimerization involves major extracellular structural rearrangements in HER1, because, in ligandoccupied receptor dimers, the intramolecular tether is broken and the receptor is opened into an extended conformation which interacts with another monomer to form a back-toback dimer [14, 15, 19] .
The original paradigm proposed for the RTKs was that the ligand induced the dimerization of monomeric unliganded receptors via ligand-cross-linking of two receptor moieties [1] . Contrary to these expectations, HER1 dimer structures showed that receptor dimerization was not directly mediated by the binding of ligand but achieved exclusively via receptorreceptor contacts (Figure 1 ), suggesting a mechanism for how unliganded receptor monomers are maintained in an 'autoinhibited' configuration.
The typical representation of the holoreceptor is depicted in Figure 1 . This generally accepted model has been derived by putting together the available crystal structures of extracellular fragments and intracellular fragments [7] [8] [9] [14] [15] [16] 19] . In this model, the extracellular domains are oriented with respect to the membrane on the basis of the historical view that receptors are protruding from the plasma membrane as antennae.
Investigating the heterogeneity of ligand binding to HER1 in cells
It has been known for three decades that EGF binding to HER1 on the cell surface displays characteristic concave-up Scatchard plots [20, 21] . As HER1 is expressed as a single translation product [22] , these concave-up Scatchard plots were interpreted as indicating the presence of two receptor populations of unknown structural origin: a small minority of high-affinity receptors with dissociation constants (K d ) of < 1 nM that mediate most signalling events, and a majority of low-affinity receptors with a K d value >1 nM [23, 24] . When crystal structures became available, the high-and lowaffinity populations were initially expected to be extended HER1 dimers and tethered HER1 monomers respectively; however, in this model, stabilization of the extended dimer configuration by one ligand molecule would facilitate the binding of a second ligand to the remaining unliganded receptor in the dimer, resulting in positive co-operativity and therefore concave-down Scatchard plots [25] .
Using global modelling of ligand-binding data as a function of receptor number, Macdonald and Pike [26] subsequently showed that EGF-binding heterogeneity could be accounted for by negative co-operativity in HER1 dimers. However, negative co-operativity requires that ligand binding to one subunit of the HER1 dimer decreases the ligand affinity of the other subunit. This would, in turn, require the interactions between ligand and the two subunits of the receptor dimer to be asymmetric, inconsistent with the symmetry observed in the back-to-back structure of HER1. A series of crystallographic structures recently showed that in dEGFR (Drosophila EGFR) the extracellular domain asymmetry is induced by the binding of the first ligand, which structurally restrains the unoccupied binding site, reducing the affinity for binding of the second ligand [27] . Interestingly, concave-up Scatchard plots were observed in preparations of the isolated extracellular region of dEGFR, in direct contrast with its human counterpart, in which concave-up plots are observed only when ligands bind to full-length receptors in cells. These differences suggest that other receptor regions, conformations and/or unknown cellular components must be involved in the regulation of ligand affinity in HER1 in the cellular environment. A better understanding of the conformation of HER1 in the plasma membrane environment should help to begin unravelling some of these questions.
Ligand-membrane distances as reporters of membrane protein conformation
Protein conformation at the plasma membrane can be investigated by measuring the distance from a specific site in the protein (e.g. the binding site of a cognate ligand) to the cell surface ( Figure 2 ). This distance can be determined from the variation of the efficiency of FRET (Förster resonance energy transfer) between fluorescent donors labelling the protein and acceptors labelling the surface, measured as a function of acceptor surface density. FRET is a phenomenon by which the excited-state energy of an optically excited fluorescent molecule (donor) is transferred to a neighbouring fluorescent molecule (acceptor) non-radiatively via intermolecular dipole coupling [28] . FRET between donors and acceptors occurs when the electronic levels of these different molecules overlap. Being a dipole-dipole interaction, FRET is extremely sensitive to short intermolecular distances (<10 nm).
Analytical expressions describing the energy-transfer process between random distributions of donors (e.g. in specific sites in proteins) and acceptors on lipid membrane surfaces have been derived for a number of geometries (see, for example, [28] ). The solutions to these equations are the distance of closest approach between the protein-bound fluorescent donor probe and a lipid acceptor chromophore at the plasma membrane. Examples of work using this FRET method include an investigation to derive the mean distance between the EGF-binding site of HER1 and the plasma membrane of cells in suspension [29] , to derive changes in conformation of α4 integrin during activation [30] , and to determine the minimum separation between the protein portion of GPI (glycosylphosphatidylinositol)-anchored proteins to the bilayer surface [31] .
Advantages of FLIM-FRET over steady-state measurement of FRET
The FRET data in the examples above were collected using cell-averaged steady-state intensity measurements (e.g. flow cytometry). The efficiency of FRET between random distribution of donors and acceptors can also be determined using FLIM (fluorescence lifetime imaging microscopy). This method images with optical resolution the shortening of the fluorescence decay time of donor-labelled EGF induced by the lipid acceptors. Being a time-resolved assay, FLIM has the advantage of being able to measure directly the time between the absorption and emission of individual photons in the FRET donor fluorophores, providing results largely free from artefacts such as photobleaching and radiative transfer which can increase the errors in the measurement.
Using the combination of FLIM and FRET, Webb et al. [32] obtained initial evidence for two types of EGF-HER1 complexes, tilted and upright, that are associated with high-affinity and low-affinity EGF binding respectively. Subsequently, with MD (molecular dynamics) simulations Kästner et al. [33] showed that, with minor rearrangements, the HER1 back-to-back dimer can be aligned almost flat on the cell membrane, leading to conformational changes which stabilize the extracellular dimer further [33] . They also showed that alignment on the cell surface and the interactions between the HER1 dimer and the upper leaflet of the membrane that follow, break the pseudo-two-fold symmetry of the HER1 extracellular region, resulting in a highly asymmetric HER1 dimer structure.
HER1 aligned on the membrane adopts key features of dEGFR asymmetry
To investigate the relevance of the MD-derived asymmetric model of the HER1 dimer [33] to EGF-binding heterogeneity (and/or the previously suggested negative co-operativity [26] ), Tynan et al. [34] extended a FLIM-FRET assay previously reported to include FRET titrations as a function of acceptor concentration together with a data analysis method based on Monte Carlo simulations. This combination allowed full quantification of the distance of closest approach between HER1-bound ligands and the surface of adherent epithelial cells, the assessment of the variation associated with the distance measurement and the rejection of potential sources of artefacts which can be inherent in standard flow cytometry (non-imaging) FRET measurements (e.g. photobleaching, non-radiative transfer and non-uniform distributions of FRET donors and acceptors).
Given the known flexibility of regions in the accepted crystallographic HER1 ectodomain dimer structure, the FRET-derived distance data obtained from HER1 that display high affinity for EGF could only be reconciled with these structural data if receptors are aligned flat on the membrane (Figure 3 ). MD simulations of doubly liganded, singly liganded and unliganded HER1 dimers aligned on a model membrane under the same conditions revealed that the asymmetry resulting from alignment on the membrane shares a number of key features with the equivalent doubly liganded and singly liganded structures observed recently in soluble dEGFR [27] . These results suggest that the structural basis for negative co-operativity is conserved from invertebrates to humans, but that, in HER1, the extracellular region asymmetry requires interactions with the plasma membrane.
Concluding remarks
FRET is commonly used at the ensemble and single-molecule levels to investigate interactions between protein species (see, The HER1 holoreceptor combines a HER1 ectodomain dimer with two bound ligands, modelled on crystallographic structures [14] [15] [16] and placed in the membrane using MD simulations [33] . Green spheres indicate the N-termini of the ligands to which donor dyes are attached. The orientation of the intracellular domain is based on electron microscopy data [39] .
for example, [35] [36] [37] ). Although less frequently employed, FRET can also be used to investigate the conformation of membrane proteins in the plasma membrane. This is derived by measuring FRET in a two-dimensional geometry, i.e. between a plane of donor-labelled protein sites and a plane of lipid acceptors in the membrane, which allow the derivation of distances of closest approach. In cases where highresolution structures are also available, this FRET method in combination with computational approaches (e.g. Monte Carlo simulations to derive distances of closest approach and MD simulations to relax structures in the membrane) can reveal which protein conformations are most consistent with the experimentally derived FRET-derived distances. Such an approach has very recently revealed a new conformation of HER1 in which in the ectodomain of the dimer is aligned in contact with the plasma membrane [34] . Interestingly, this conformation suggests that the structural basis for negative co-operativity is conserved from invertebrates to humans, solving a 30-year-old puzzle in EGFR research. 
